ArticlePeerJ2020
Combating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses.
Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Disrupting the vicious cycle of malnutrition and enteropathy: advancing strategies to improve child physical and neurocognitive outcomes.Frontiers in public health · 2026Review
- Fomite workshop recommendations addressing the role of surfaces in virus transmission in the built environment.mSphere · 2025Review
- Virucidal Approaches for Hemorrhagic Fever Viruses.Viruses · 2025Review
- Rapid virucidal activity of an air sanitizer against aerosolized MS2 and Phi6 phage surrogates for non-enveloped and enveloped vertebrate viruses, including SARS-CoV-2.Applied and environmental microbiology · 2025Article
- Differing Susceptibilities to Certain Microbicidal Chemistries among Three Representative Enveloped Viruses.Microorganisms · 2024Article
- Inactivation kinetics of benzalkonium chloride and ethanol-based hand sanitizers against a betacoronavirus and an alphacoronavirus.Infection prevention in practice · 2023Article
- Efficacy of microbicidal actives and formulations for inactivation of Lassa virus in suspension.Scientific reports · 2023Article
- Review
- Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives.Life (Basel, Switzerland) · 2022Article
- Virucidal efficacy of laundry sanitizers against SARS-CoV-2 and other coronaviruses and influenza viruses.Scientific reports · 2022Article
- Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2.American journal of infection control · 2022Article
- Mechanical Wiping Increases the Efficacy of Liquid Disinfectants on SARS-CoV-2.Frontiers in microbiology · 2022Article
- The propensity of fomite spread of SARS-CoV-2 virus through produce supply chain.Bulletin of the National Research Centre · 2022Review
- Recent advancements in the measurement of pathogenic airborne viruses.Journal of hazardous materials · 2021Review
- SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium.The Journal of hospital infection · 2021Article
- Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.Scientific reports · 2021Article
- Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus.Frontiers in public health · 2021Article
- Article
- Microbicidal actives with virucidal efficacy against SARS-CoV-2.American journal of infection control · 2020Article
- SARS-CoV-2 and Risk to Food Safety.Frontiers in nutrition · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan City, China, late in December 2019 is an example of an emerging zoonotic virus that threatens public health and international travel and commerce. When such a virus emerges, there is often insufficient specific information available on mechanisms of virus dissemination from animal-to-human or from person-to-person, on the level or route of infection transmissibility or of viral release in body secretions/excretions, and on the survival of virus in aerosols or on surfaces. The effectiveness of available virucidal agents and hygiene practices as interventions for disrupting the spread of infection and the associated diseases may not be clear for the emerging virus. In the present review, we suggest that approaches for infection prevention and control (IPAC) for SARS-CoV-2 and future emerging/re-emerging viruses can be invoked based on pre-existing data on microbicidal and hygiene effectiveness for related and unrelated enveloped viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.